Kidney Transplant Allocation with CMV Seromatching Reduces CMV Infection without Affecting Wait Times.

被引：0
|
作者：
Narra, A. [1 ]
Strasfeld, L. [2 ]
Basuli, D. [1 ]
Stack, M. [1 ]
Langewisch, E. [3 ]
Olyaei, A. [1 ]
Norman, D. [1 ,4 ]
Lockridge, J. [1 ,4 ]
机构：
[1] Oregon Hlth & Sci Univ, Transplant Nephrol, Portland, OR 97201 USA
[2] OHSU, Infect Dis, Portland, OR USA
[3] Univ Nebraska Med Ctr, Transplant Nephrol, Omaha, NE USA
[4] Portland VA, Transplant Nephrol, Portland, OR USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
185
引用
收藏
页码：318 / 319
页数：2
相关论文
共 50 条
  • [21] NEWFOUND RISK-FACTORS FOR CMV-INFECTION IN KIDNEY TRANSPLANT PATIENTS
    Varga, Marina
    Remport, Adam
    Rajczy, Katalin
    Toronyi, Eva
    Peter, Antal
    Sarvary, Eniko
    Fazakas, Janos
    Galffy, Zsuzsanna
    Fehervari, Imre
    Jaray, Jeno
    TRANSPLANT INTERNATIONAL, 2009, 22 : 158 - 158
  • [22] Evaluation of telomeric KIR genes and their association with CMV infection in kidney transplant recipients
    Farzamikia, Negin
    Hejazian, Seyyedeh Mina
    Haghi, Mehdi
    Hejazian, Seyyed Sina
    Vahed, Sepideh Zununi
    Ardalan, Mohammadreza
    IMMUNOGENETICS, 2022, 74 (02) : 207 - 212
  • [23] Longer valganciclovir treatment halves kidney transplant patients' incidence of CMV infection
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (10) : 556 - 556
  • [24] CMV Infection and Lymphopenia: Warning Markers of Pneumocystis Pneumonia in Kidney Transplant Recipients
    Eberl, Isabelle
    Binquet, Christine
    Guilloteau, Adrien
    Legendre, Mathieu
    Dalle, Frederic
    Piroth, Lionel
    Tinel, Claire
    Blot, Mathieu
    TRANSPLANT INTERNATIONAL, 2024, 37
  • [25] Risk Stratification of Cytomegalovirus Seropositive Kidney Transplant Recipients for CMV Infection.
    Azar, M. M.
    Baghban, A.
    Belfield, K.
    Assi, R.
    Malinis, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 460 - 460
  • [26] Cytomegalovirus infection in seromismatched lung transplant recipients with and without prophylaxis with CMV immunoglobulin
    Kathawalla, SA
    Stillwell, PC
    Gordon, S
    Haug, M
    Perl, M
    Arroliga, AC
    Mehta, AC
    Avery, R
    Kirby, T
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (06) : 16 - 16
  • [27] Diagnostic usefulness of the cytomegalovirus (CMV)-specific T cell-based assay for predicting CMV infection after kidney transplant
    Kim, Taeeun
    Lee, Hyun-Jeong
    Kim, Sun-Mi
    Jung, Joo Hee
    Shin, Sung
    Kim, Young-Hoon
    Sung, Heungsup
    Chong, Yong Pil
    Lee, Sang-Oh
    Choi, Sang-Ho
    Kim, Yang Soo
    Woo, Jun Hee
    Kim, Sung-Han
    Han, Duck Jong
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (02): : 438 - +
  • [28] EVEROLIMUS REDUCES CYTOMEGALOVIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTS RECEIVING PREEMPTIVE CMV PROPHYLAXIS
    Spagnoletti, Gionata
    Salerno, Maria Paola
    Apponi, Francesca
    Bianchi, Valentina
    Favi, Evaldo
    Jose, Albero Pedroso
    Romagnoli, Jacopo
    Citterio, Franco
    TRANSPLANT INTERNATIONAL, 2015, 28 : 98 - 98
  • [29] Comparison of the Commercial QuantiFERON-CMV and Overlapping Peptide-based ELISPOT Assays for Predicting CMV Infection in Kidney Transplant Recipients
    Kwon, Ji-Soo
    Kim, Taeeun
    Kim, Sun-Mi
    Sung, Heungsup
    Shin, Sung
    Kim, Young Hoon
    Shin, Eui-Cheol
    Kim, Sung-Han
    Han, Duck Jong
    IMMUNE NETWORK, 2017, 17 (05) : 317 - 325
  • [30] Comparison of Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV Quantiferon Gamma Interferon-Releasing Assays in Assessing Risk of CMV Infection in Kidney Transplant Recipients
    Abate, Davide
    Saldan, Alda
    Mengoli, Carlo
    Fiscon, Marta
    Silvestre, Cristina
    Fallico, Loredana
    Peracchi, Marta
    Furian, Lucrezia
    Cusinato, Riccardo
    Bonfante, Luciana
    Rossi, Barbara
    Marchini, Francesco
    Sgarabotto, Dino
    Rigotti, Paolo
    Palu, Giorgio
    JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (08) : 2501 - 2507
12345